New paper on Huntingtons
Our new paper #62: “The predicted structure of the headpiece of the Huntington protein and its implications for Huntington’s Disease.” just came out in the Journal of Molecular Biology.
Read moreOur new paper #62: “The predicted structure of the headpiece of the Huntington protein and its implications for Huntington’s Disease.” just came out in the Journal of Molecular Biology.
Read moreWe have had some exciting results regarding new possible drug leads for Alzheimer’s. We hope to be submitting these soon for publication.
Read moreWe’ve been using our new Protomol (Core B4) core to study the activation of src Kinase, an enzyme that is involved in the onset of some kinds of cancer.
Read moreDel has been involved in the development of new software methods (Ocker) for the chaperonin inhibitor project.
Read moreWe presented our results regarding new possible drugs to fight Alzheimer’s Disease at a Stanford University meeting organized by the NIH Roadmap Nanomedicine center.
Read moreDuring this year we published our first work on some of the molecular interactions that occur during the initial stages of viral infection, and how they can impact current antivirus…
Read moreWe have also started to apply the drug design methods used in Alzheimer’s to HD.
Read moreProf. Pande has presented the results on HD at a variety of Stanford internal conferences and meetings. People have been excited and interested in the results.
Read moreWe presented our results regarding new possible drugs (small molecule leads) to fight Alzheimer’s Disease at a recent meeting at Stanford, supported by the NIH Roadmap Nanomedicine center and NIH…
Read moreThe first of the papers has come out (see paper #58 on our Results page: “Simulating oligomerization at experimental concentrations and long timescales: A Markov state model approach”). In many…
Read more